Maruyama Y
Radiology. 1983 Jul;148(1):247-51. doi: 10.1148/radiology.148.1.6856844.
A feasibility trial of californium-252 neutron brachytherapy combined with fractionated cobalt-60 therapy for advanced but localized stage T4 tonsillar-retromolar carcinoma is described. Seven patients with primary tumors who were not suitable for conventional radical surgery, chemoradiotherapy and surgery, or surgery plus irradiation were treated. There was complete tumor response in all cases.
本文描述了一项关于锎 - 252中子近距离治疗联合分次钴 - 60治疗晚期但局限的T4扁桃体 - 磨牙后区癌的可行性试验。对7例不适合传统根治性手术、放化疗联合手术或手术加放疗的原发性肿瘤患者进行了治疗。所有病例均出现肿瘤完全缓解。